Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Accounts Payables (2019 - 2025)

Silo Pharma's Accounts Payables history spans 7 years, with the latest figure at $636237.0 for Q3 2025.

  • For Q3 2025, Accounts Payables fell 34.59% year-over-year to $636237.0; the TTM value through Sep 2025 reached $636237.0, down 34.59%, while the annual FY2024 figure was $1.6 million, 125.15% up from the prior year.
  • Accounts Payables for Q3 2025 was $636237.0 at Silo Pharma, down from $977795.0 in the prior quarter.
  • Across five years, Accounts Payables topped out at $1.6 million in Q4 2024 and bottomed at $2206.0 in Q1 2022.
  • The 5-year median for Accounts Payables is $527087.0 (2021), against an average of $610286.7.
  • The largest annual shift saw Accounts Payables crashed 99.07% in 2022 before it skyrocketed 956.22% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $417937.0 in 2021, then decreased by 12.85% to $364216.0 in 2022, then soared by 93.15% to $703488.0 in 2023, then skyrocketed by 125.15% to $1.6 million in 2024, then plummeted by 59.83% to $636237.0 in 2025.
  • Per Business Quant, the three most recent readings for SILO's Accounts Payables are $636237.0 (Q3 2025), $977795.0 (Q2 2025), and $1.1 million (Q1 2025).